- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Placebo and active control dose response study of rivoglitazone in type 2 diabetics
Total 498841 results
-
Regeneron PharmaceuticalsSanofiTerminatedHeterozygous Familial Hypercholesterolemia | Non-familial HypercholesterolemiaUnited States, Bulgaria, Estonia, Russian Federation, South Africa, Ukraine
-
ExelixisArcus Biosciences, Inc.RecruitingAdvanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid TumorsUnited States
-
Akdeniz UniversityCompletedInfertility | Female Infertility | Frozen-thawed Embryo TransferTurkey
-
PegBio Co., Ltd.Not yet recruiting
-
Atrogi ABKey2Compliance; CRS Clinical Research ServicesCompleted
-
GlaxoSmithKlineWake Forrest Baptist HealthTerminated
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus Type 2United States
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes MellitusRussian Federation
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Austria, Canada, Italy, Netherlands, Spain, United Kingdom, Taiwan, Thailand, Bulgaria, Belgium, Germany, Korea, Republic of, Hungary, Philippines, China, Malaysia, Hong Kong, New Zealand, Argentina, Czechia, Slovakia, Braz... and more
-
Merck Sharp & Dohme LLCPfizerCompleted
-
AstraZenecaCompleted
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Mexico, Argentina
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Germany
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Germany, Slovakia, Hungary, United Kingdom
-
GlaxoSmithKlineCompleted
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Mexico, Taiwan, United States, Israel, Russian Federation, Slovakia, Ukraine, Guatemala, Peru, Romania
-
Merck Sharp & Dohme LLCTerminated
-
Ono Pharmaceutical Co. LtdCompletedType 2 Diabetes MellitusJapan
-
Lexicon PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Solvay PharmaceuticalsCompletedType 2 Diabetes MellitusUnited Kingdom
-
PfizerCompletedCOVID-19United States, Russian Federation, Thailand, Czechia, Colombia, Bulgaria, Japan, South Africa, Turkey, Argentina, Hungary, Malaysia, Mexico, Poland, Spain, Ukraine, Brazil
-
PfizerCompletedCOVID-19United States, Korea, Republic of, Russian Federation, Czechia, Turkey, Malaysia, South Africa, Bulgaria, Poland, Hungary, Argentina, Brazil, Colombia, Japan, Mexico, Puerto Rico, Spain, Thailand, Ukraine, India
-
PfizerCompletedDiabetes Mellitus Type 2United States
-
Response PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
TakedaCompleted
-
Haisco Pharmaceutical Group Co., Ltd.CompletedType 2 Diabetes MellitusChina
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Romania, United States, Japan, Russian Federation, Spain, Canada, Germany, Latvia, Mexico, Brazil
-
Merck Sharp & Dohme LLCCompleted
-
Rajarata University, Sri LankaCompletedType 2 Diabetes MellitusSri Lanka
-
Astellas Pharma Korea, Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Oramed, Ltd.IntegriumCompletedType 2 Diabetes MellitusUnited States
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Canada
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Korea, Republic of, China
-
Merck Sharp & Dohme LLCCompleted
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Romania, Canada, Russian Federation, Czech Republic, Slovakia, Mexico
-
Akros Pharma Inc.CompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaCompletedType 2 Diabetes MellitusJapan
-
The Hong Kong Polytechnic UniversityOur Lady of Maryknoll HospitalUnknownType 2 Diabetes MellitusChina
-
Lexicon PharmaceuticalsCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaCompleted